Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11168806.5Aexternal-prioritypatent/EP2383271B1/en
Application filed by Kyorin Pharmaceutical Co., LtdfiledCriticalKyorin Pharmaceutical Co., Ltd
Publication of CY1114328T1publicationCriticalpatent/CY1114328T1/en
Παρέχονται στο παρόν αμινοκινολόνες και φαρμακευτικώς αποδεκτά παράγωγα αυτών. Σε ορισμένες υλοποιήσεις, παρέχονται στο παρόν ενώσεις, συνθέσεις και μέθοδοι για αντιμετώπιση, πρόληψη ή βελτίωση διαμεσολαβούμενων από GSK-3 νόσων.Aminoquinolones and pharmaceutically acceptable derivatives thereof are provided herein. In certain embodiments, compounds, compositions, and methods for treating, preventing, or ameliorating GSK-3-mediated diseases are provided herein.
CY20131100646T2006-03-132013-07-26
AMINOCINOLONES AS GSK-3 INHIBITORS
CY1114328T1
(en)
Compounds derived from substituted aromatic heterobicycles, py3 kinase inhibitors; pharmaceutical composition; Useful in the treatment of cancer, melanomas, glioblastomas, among other diseases.